Flash e-reader

 Go to e-reader chapter








Table 5.14d

Unadjusted Patient Survival, Living Donor Kidney Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2007 - 2008) (Tx 2007 - 2008) (Tx 2003 - 2008) (Tx 1998 - 2008)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 10,773 99.5% 0.1% 10,773 98.6% 0.1% 34,056 91.6% 0.2% 58,235 77.6% 0.3%
Primary Diagnosis Glomerular Diseases 3,056 99.7% 0.1% 3,056 99.3% 0.2% 9,743 95.4% 0.3% 17,256 86.4% 0.4%
Diabetes 2,374 99.3% 0.2% 2,374 98.0% 0.3% 7,441 84.9% 0.5% 12,678 59.6% 0.7%
Hypertensive Nephrosclerosis 1,779 99.3% 0.2% 1,779 98.1% 0.3% 5,357 89.9% 0.5% 8,136 73.1% 0.9%
Polycystic Kidneys 1,294 99.3% 0.2% 1,294 99.0% 0.3% 3,830 96.0% 0.4% 6,058 85.5% 0.8%
Tubular and Interstitial Diseases 613 99.5% 0.3% 613 98.4% 0.5% 2,068 90.4% 0.8% 3,826 80.2% 0.9%
Renovascular & Other Vascular Diseases 229 99.6% 0.4% 229 98.7% 0.8% 928 91.1% 1.1% 1,976 74.1% 1.5%
Congenital, Rare Familial, & Metabolic Disorders 354 99.7% 0.3% 354 98.6% 0.6% 1,274 96.2% 0.6% 2,265 90.3% 1.0%
Neoplasms 33 100.0% 0.0% 33 100.0% 0.0% 133 85.3% 4.0% 245 68.6% 5.0%
Other 1,032 99.6% 0.2% 1,032 98.1% 0.4% 3,231 92.0% 0.6% 5,726 81.3% 0.8%
Unknown 9 100.0% 0.0% 9 100.0% 0.0% 51 86.6% 5.8% 69 68.8% 10.0%


Source: OPTN/SRTR Data as of October 1, 2010.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on kidney and kidney-pancreas transplants.

Multi-organ transplants are excluded.

Dialysis needed within first week excludes patients whose graft failed before the end of the week.